Igenica, Inc. To Present At The 21st Annual BioCentury Future Leaders In The Biotech Industry
Published: Mar 25, 2014
Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that Mary Haak-Frendscho, Ph.D., chief executive officer, will present a company overview at the 21st Annual BioCentury Future Leaders In The Biotech Industry conference.
Help employers find you! Check out all the jobs and post your resume.